MGC Pharmaceuticals Limited
MGCLF · OTC
12/30/2023 | 6/30/2023 | 12/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $1,106,552 | $18,261 | $56,744 | $53,737 |
| - Cash | $6,482 | $240 | $1,134 | $1,886 |
| + Debt | $9,647 | $9,755 | $10,029 | $4,353 |
| Enterprise Value | $1,109,717 | $27,775 | $65,640 | $56,203 |
| Revenue | $600 | $725 | $2,663 | $2,166 |
| % Growth | -17.3% | -72.8% | 22.9% | – |
| Gross Profit | -$582 | -$162 | $1,073 | $1,113 |
| % Margin | -97.1% | -22.3% | 40.3% | 51.4% |
| EBITDA | -$5,972 | -$9,528 | -$10,806 | -$7,552 |
| % Margin | -996.2% | -1,314.4% | -405.8% | -348.7% |
| Net Income | -$7,076 | -$9,941 | -$10,882 | -$12,909 |
| % Margin | -1,180.2% | -1,371.3% | -408.6% | -596% |
| EPS Diluted | -0.003 | -3.27 | -3.8 | -4.73 |
| % Growth | 99.9% | 13.9% | 19.7% | – |
| Operating Cash Flow | -$7,906 | -$5,231 | -$6,754 | -$6,765 |
| Capital Expenditures | -$17 | $46 | -$236 | -$321 |
| Free Cash Flow | -$7,923 | -$5,185 | -$6,990 | -$7,086 |